CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President & CEO bought 306,813 shares at an average $0.91 ($278,132)
- 4 Open-market buy President & CEO bought 93,091 shares at $0.84 ($78,196)
- 4 Open-market buy Director bought 8,600 shares at $2.90 ($24,940)
- 4 Open-market buy President & CEO bought 150,000 shares at $2.76 ($414,000)
- 4 Open-market buy President & CEO bought 73,385 shares at $2.75 ($201,809)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Operating & Legal Office bought 13,725 shares at $2.91 ($39,940)
- 4 Open-market buy President & CEO bought 7,172 shares at $2.28 ($16,352)
- 4 Open-market buy President & CEO bought 237,941 shares at an average $2.25 ($534,743)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 30 · 585 filings